Hazard ratios with 95% CIs from univariable Cox proportional hazard models of overall survival
| Variable . | Hazard ratio . | 95% CI for HR . | P value . | |
|---|---|---|---|---|
| Lower . | Upper . | |||
| Female sex | 0.77 | 0.18 | 3.31 | 0.725 |
| Family Hx of CVD | 0.52 | 0.19 | 1.40 | 0.196 |
| Previous IHD | 2.98 | 1.15 | 7.74 | 0.027 |
| Previous CABG | 0.95 | 0.13 | 7.23 | 0.960 |
| Previous PTCA | 0.33 | 0.59 | 4.69 | 0.334 |
| Elevated BP | 0.61 | 0.23 | 1.60 | 0.315 |
| High cholesterol | 0.99 | 0.36 | 2.68 | 0.982 |
| Diabetes | 1.29 | 0.48 | 3.52 | 0.613 |
| Smoking | 0.443 | |||
| Never | 1 | Reference | ||
| Current | 1.87 | 0.57 | 6.09 | 0.300 |
| Ex | 1.00 | 0.25 | 4.00 | 0.997 |
| Infarct artery | 1 | 0.477 | ||
| LAD | 2.32 | Reference | ||
| RCA | 1.65 | 0.80 | 6.72 | 0.121 |
| LCx | 1.58 | 0.21 | 12.90 | 0.631 |
| Other | 0.20 | 12.35 | 0.661 | |
| Appropriate ICD activation | 0.75 | 0.29 | 1.99 | 0.569 |
| VF vs. VT appropriate activation | 0.77 | 0.09 | 6.74 | 0.815 |
| Shock vs. ATP termination of appropriate activation | 0.92 | 0.17 | 5.12 | 0.924 |
| RBBB morphology | 2.63 | 0.99 | 6.67 | 0.051 |
| Age—per 10-year increase | 1.50 | 0.98 | 2.19 | 0.060 |
| LVEF—per 10% increase | 0.63 | 0.36 | 1.12 | 0.112 |
| Variable . | Hazard ratio . | 95% CI for HR . | P value . | |
|---|---|---|---|---|
| Lower . | Upper . | |||
| Female sex | 0.77 | 0.18 | 3.31 | 0.725 |
| Family Hx of CVD | 0.52 | 0.19 | 1.40 | 0.196 |
| Previous IHD | 2.98 | 1.15 | 7.74 | 0.027 |
| Previous CABG | 0.95 | 0.13 | 7.23 | 0.960 |
| Previous PTCA | 0.33 | 0.59 | 4.69 | 0.334 |
| Elevated BP | 0.61 | 0.23 | 1.60 | 0.315 |
| High cholesterol | 0.99 | 0.36 | 2.68 | 0.982 |
| Diabetes | 1.29 | 0.48 | 3.52 | 0.613 |
| Smoking | 0.443 | |||
| Never | 1 | Reference | ||
| Current | 1.87 | 0.57 | 6.09 | 0.300 |
| Ex | 1.00 | 0.25 | 4.00 | 0.997 |
| Infarct artery | 1 | 0.477 | ||
| LAD | 2.32 | Reference | ||
| RCA | 1.65 | 0.80 | 6.72 | 0.121 |
| LCx | 1.58 | 0.21 | 12.90 | 0.631 |
| Other | 0.20 | 12.35 | 0.661 | |
| Appropriate ICD activation | 0.75 | 0.29 | 1.99 | 0.569 |
| VF vs. VT appropriate activation | 0.77 | 0.09 | 6.74 | 0.815 |
| Shock vs. ATP termination of appropriate activation | 0.92 | 0.17 | 5.12 | 0.924 |
| RBBB morphology | 2.63 | 0.99 | 6.67 | 0.051 |
| Age—per 10-year increase | 1.50 | 0.98 | 2.19 | 0.060 |
| LVEF—per 10% increase | 0.63 | 0.36 | 1.12 | 0.112 |
CI, confidence interval; HR, hazard ratio; Hx, history; CVD, cardiovascular disease; IHD, ischaemic heart disease; CABG, coronary artery bypass grafting; PTCA, percutaneous transluminal coronary angioplasty; BP, blood pressure; LAD, left anterior descending; RCA, right coronary artery; LCx, left circumflex; ICD, implantable cardioverter–defibrillator; VF, ventricular fibrillation; VT, ventricular tachycardia; ATP, anti-tachycardia pacing; RBBB, right bundle branch block; LVEF, left ventricular ejection fraction.
Hazard ratios with 95% CIs from univariable Cox proportional hazard models of overall survival
| Variable . | Hazard ratio . | 95% CI for HR . | P value . | |
|---|---|---|---|---|
| Lower . | Upper . | |||
| Female sex | 0.77 | 0.18 | 3.31 | 0.725 |
| Family Hx of CVD | 0.52 | 0.19 | 1.40 | 0.196 |
| Previous IHD | 2.98 | 1.15 | 7.74 | 0.027 |
| Previous CABG | 0.95 | 0.13 | 7.23 | 0.960 |
| Previous PTCA | 0.33 | 0.59 | 4.69 | 0.334 |
| Elevated BP | 0.61 | 0.23 | 1.60 | 0.315 |
| High cholesterol | 0.99 | 0.36 | 2.68 | 0.982 |
| Diabetes | 1.29 | 0.48 | 3.52 | 0.613 |
| Smoking | 0.443 | |||
| Never | 1 | Reference | ||
| Current | 1.87 | 0.57 | 6.09 | 0.300 |
| Ex | 1.00 | 0.25 | 4.00 | 0.997 |
| Infarct artery | 1 | 0.477 | ||
| LAD | 2.32 | Reference | ||
| RCA | 1.65 | 0.80 | 6.72 | 0.121 |
| LCx | 1.58 | 0.21 | 12.90 | 0.631 |
| Other | 0.20 | 12.35 | 0.661 | |
| Appropriate ICD activation | 0.75 | 0.29 | 1.99 | 0.569 |
| VF vs. VT appropriate activation | 0.77 | 0.09 | 6.74 | 0.815 |
| Shock vs. ATP termination of appropriate activation | 0.92 | 0.17 | 5.12 | 0.924 |
| RBBB morphology | 2.63 | 0.99 | 6.67 | 0.051 |
| Age—per 10-year increase | 1.50 | 0.98 | 2.19 | 0.060 |
| LVEF—per 10% increase | 0.63 | 0.36 | 1.12 | 0.112 |
| Variable . | Hazard ratio . | 95% CI for HR . | P value . | |
|---|---|---|---|---|
| Lower . | Upper . | |||
| Female sex | 0.77 | 0.18 | 3.31 | 0.725 |
| Family Hx of CVD | 0.52 | 0.19 | 1.40 | 0.196 |
| Previous IHD | 2.98 | 1.15 | 7.74 | 0.027 |
| Previous CABG | 0.95 | 0.13 | 7.23 | 0.960 |
| Previous PTCA | 0.33 | 0.59 | 4.69 | 0.334 |
| Elevated BP | 0.61 | 0.23 | 1.60 | 0.315 |
| High cholesterol | 0.99 | 0.36 | 2.68 | 0.982 |
| Diabetes | 1.29 | 0.48 | 3.52 | 0.613 |
| Smoking | 0.443 | |||
| Never | 1 | Reference | ||
| Current | 1.87 | 0.57 | 6.09 | 0.300 |
| Ex | 1.00 | 0.25 | 4.00 | 0.997 |
| Infarct artery | 1 | 0.477 | ||
| LAD | 2.32 | Reference | ||
| RCA | 1.65 | 0.80 | 6.72 | 0.121 |
| LCx | 1.58 | 0.21 | 12.90 | 0.631 |
| Other | 0.20 | 12.35 | 0.661 | |
| Appropriate ICD activation | 0.75 | 0.29 | 1.99 | 0.569 |
| VF vs. VT appropriate activation | 0.77 | 0.09 | 6.74 | 0.815 |
| Shock vs. ATP termination of appropriate activation | 0.92 | 0.17 | 5.12 | 0.924 |
| RBBB morphology | 2.63 | 0.99 | 6.67 | 0.051 |
| Age—per 10-year increase | 1.50 | 0.98 | 2.19 | 0.060 |
| LVEF—per 10% increase | 0.63 | 0.36 | 1.12 | 0.112 |
CI, confidence interval; HR, hazard ratio; Hx, history; CVD, cardiovascular disease; IHD, ischaemic heart disease; CABG, coronary artery bypass grafting; PTCA, percutaneous transluminal coronary angioplasty; BP, blood pressure; LAD, left anterior descending; RCA, right coronary artery; LCx, left circumflex; ICD, implantable cardioverter–defibrillator; VF, ventricular fibrillation; VT, ventricular tachycardia; ATP, anti-tachycardia pacing; RBBB, right bundle branch block; LVEF, left ventricular ejection fraction.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
